ECOR electroCore, Inc. Stock Quote

ECOR [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-0.27	Insider Own	1.50%	Shs Outstand	70.67M	Perf Week	1.21%
Market Cap	28.73M	Forward P/E	-	EPS next Y	-0.22	Insider Trans	20.68%	Shs Float	62.15M	Perf Month	-15.63%
Income	-17.40M	PEG	-	EPS next Q	-0.07	Inst Own	19.20%	Short Float	1.59%	Perf Quarter	-25.09%
Sales	6.10M	P/S	4.71	EPS this Y	51.70%	Inst Trans	-3.89%	Short Ratio	2.61	Perf Half Y	-46.25%
Book/sh	0.45	P/B	0.90	EPS next Y	21.40%	ROA	-43.80%	Target Price	2.80	Perf Year	-75.27%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-52.40%	52W Range	0.27 - 1.85	Perf YTD	-30.80%
Dividend	-	P/FCF	-	EPS past 5Y	12.10%	ROI	-47.10%	52W High	-78.21%	Beta	1.03
Dividend %	-	Quick Ratio	6.60	Sales past 5Y	84.60%	Gross Margin	77.50%	52W Low	52.06%	ATR	0.04
Employees	52	Current Ratio	6.90	Sales Q/Q	58.30%	Oper. Margin	-	RSI (14)	48.42	Volatility	12.55% 11.30%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	30.10%	Profit Margin	-	Rel Volume	0.11	Prev Close	0.39
Shortable	Yes	LT Debt/Eq	0.00	Earnings	May 05 AMC	Payout	-	Avg Volume	377.82K	Price	0.40
Recom	2.00	SMA20	5.92%	SMA50	-16.34%	SMA200	-44.71%	Volume	40,088	Change	2.21%

Aug-14-20

Upgrade

BTIG Research

Neutral → Buy

$3.50

Nov-14-19

Downgrade

JMP Securities

Mkt Outperform → Mkt Perform

Sep-26-19

Resumed

Cantor Fitzgerald

Neutral

May-30-19

Downgrade

Cantor Fitzgerald

Overweight → Neutral

May-15-19

Downgrade

BTIG Research

Buy → Neutral

May-09-19

Initiated

Noble Capital Markets

Outperform

Sep-21-18

Initiated

Cantor Fitzgerald

Overweight

May-24-22 08:00AM	electroCore, Inc. Announces gammaCore Non-Invasive Vagus Nerve Stimulator Available Through National Spine and Pain Centers GlobeNewswire -6.54%
May-18-22 08:00AM	electroCore to Participate at Upcoming Investor Conferences GlobeNewswire
May-14-22 10:40AM	We're Keeping An Eye On electroCore's (NASDAQ:ECOR) Cash Burn Rate Simply Wall St.
May-06-22 08:26AM	ECOR: First Quarter 2022 Financial and Operational Results Zacks Small Cap Research
08:25AM	ECOR: First Quarter 2022 Financial and Operational Results Zacks Small Cap Research
May-05-22 04:00PM	electroCore Announces Record First Quarter 2022 Financial Results GlobeNewswire
Apr-28-22 08:00AM	electroCore to Announce First Quarter 2022 Financial Results on May 5 GlobeNewswire -12.27%
Apr-26-22 08:00AM	electroCore Completes Sale of New Jersey Tax Benefits GlobeNewswire
Apr-21-22 08:00AM	electroCore Announces Publication of Investigator-Initiated Trial Data for SAVIOR-1 in COVID-19 Patients in Frontiers in Neurology GlobeNewswire
Apr-19-22 08:00AM	gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Selected for Department of Defense Biotech Optimized for Operational Solutions and Tactics (BOOST) Program GlobeNewswire
Apr-12-22 08:00AM	electroCore Provides Business Update and Select First Quarter 2022 Financial Guidance GlobeNewswire
Apr-05-22 08:00AM	electroCore Announces Exclusive License Agreement with Teijin for Japan Territory GlobeNewswire
Mar-23-22 08:00AM	electroCore Announces Dr. Peter Staats to Keynote the Fifth Annual Bioelectronic Medicine Forum in New York GlobeNewswire
Mar-22-22 08:00AM	electroCore to Present at 2022 Maxim Virtual Growth Conference GlobeNewswire +6.17%
Mar-14-22 05:56AM	ECOR: 2021 Results Zacks Small Cap Research -6.88%
Mar-10-22 04:01PM	electroCore Announces Fourth Quarter and Full Year 2021 Financial Results GlobeNewswire
Mar-09-22 11:30AM	electroCore Announces Changes to its Board of Directors GlobeNewswire
Mar-07-22 04:01PM	electroCore to Present at 34th Annual Roth Conference GlobeNewswire
Mar-03-22 08:00AM	electroCore to Announce Fourth Quarter and Year Ended December 31, 2021 Financial Results on Thursday, March 10 GlobeNewswire
Feb-22-22 07:40AM	ECOR: Different Strokes for Different Folks Zacks Small Cap Research
Feb-09-22 08:00AM	Data Presented at 2022 International Stroke Congress Suggests Role for Non-invasive Vagus Nerve Stimulation (nVNS) for Treatment of Acute Stroke GlobeNewswire
Feb-01-22 08:00AM	electroCore, Inc. Announces Completion of Enrollment in the TRANSIT Study of non-Invasive Vagus Nerve Stimulation (nVNS) in Post-Operative Ileus GlobeNewswire
Jan-25-22 08:00AM	electroCore, Inc. Announces Three Abstracts to be Presented at International Stroke Conference 2022 GlobeNewswire
Jan-18-22 08:00AM	electroCore Announces Shareholder Letter and Full-Year 2021 Business Update GlobeNewswire +8.29%
04:32AM	ECOR: New Distribution Agreements Complement E-Commerce Initiative Zacks Small Cap Research
Jan-12-22 05:27PM	ECOR Stock Alert: Why Is electroCore Soaring Today? InvestorPlace +64.03%
08:00AM	gammaCore Non-Invasive Vagus Nerve Stimulation(nVNS) Receives Breakthrough Device Designation for Treatment of Posttraumatic Stress Disorder (PTSD) GlobeNewswire
Jan-11-22 08:00AM	electroCore, Inc. Broadens Patient Access to gammaCore with Launch of U.S. Telehealth Portal and Online Store GlobeNewswire
Jan-10-22 04:01PM	electroCore Announces Publication of PREMIUM II Trial of gammaCore (Non-Invasive Vagus Nerve Stimulation; nVNS) for the Prevention of Migraine GlobeNewswire
Jan-04-22 08:00AM	electroCore to Present at H.C. Wainwright BIOCONNECT Virtual Conference GlobeNewswire
Dec-16-21 08:00AM	electroCore, Inc. Provides Update on Global Distribution Partners GlobeNewswire
Dec-15-21 08:00AM	electroCore, Inc. Announces The Launch of a New Online Shop in the United Kingdom GlobeNewswire
Dec-14-21 08:00AM	electroCore, Inc. Provides Update on nVNS to Treat Post Traumatic Stress Disorder GlobeNewswire -5.75%
Dec-13-21 08:55AM	electroCore Announces New Patent for Stroke and TIA Treatment GlobeNewswire
Nov-11-21 08:00AM	electroCore to Participate at Canaccord Genuity MedTech & Diagnostics Forum GlobeNewswire
Nov-08-21 06:41AM	ECOR: Third Quarter Results Zacks Small Cap Research
Nov-04-21 04:01PM	electroCore Announces Third Quarter 2021 Financial Results GlobeNewswire
09:04AM	Quite a few insiders invested in electroCore, Inc. (NASDAQ:ECOR) last year which is positive news for shareholders Simply Wall St.
Oct-21-21 08:00AM	electroCore to Announce Third Quarter 2021 Financial Results on Thursday, November 4th GlobeNewswire
Oct-20-21 08:00AM	electroCore Announces Publication Reviewing the Prescribing of gammaCore for the Treatment of Cluster Headache in England GlobeNewswire
Oct-14-21 08:00AM	electroCore Announces Regulatory Approval in Canada to Treat Adolescent Migraine GlobeNewswire
Oct-12-21 08:00AM	electroCore Provides Business Update and Select Third Quarter 2021 Financial Guidance GlobeNewswire
Oct-07-21 08:00AM	electroCore Announces Acceptance of Motion to Dismiss in the Federal Court Securities Class Action Suit GlobeNewswire
Oct-04-21 04:30PM	36 of the Best Ideas Companies to Present at the Fall Harvest - Best Ideas from the Buy-Side Virtual Investor Conference on October 5th - 8th, 2021 ACCESSWIRE
Sep-30-21 09:05AM	electroCore Presentation at the Cantor Fitzgerald Virtual Global Healthcare Conference GlobeNewswire
Sep-29-21 08:00AM	electroCore Announces Open Access and Submission of Manuscript from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients GlobeNewswire
Sep-23-21 10:50AM	2 Strong Buy Penny Stocks That Are Headed to a Triple-Digit Gain TipRanks +9.28%
08:00AM	electroCore to Participate at Upcoming Investor Conferences GlobeNewswire
Sep-20-21 08:00AM	electroCore Announces Peter Cuneo as Board Chairman GlobeNewswire
Sep-14-21 08:00AM	electroCore Announces 510(k) Clearance of gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Paroxysmal Hemicrania and Hemicrania Continua GlobeNewswire -5.91%
Aug-31-21 08:00AM	electroCore to Present at the HC Wainwright 23rd Annual Global Investment Conference GlobeNewswire
Aug-24-21 08:00AM	electroCore Announces New Reseller Agreement with Red One Medical Devices, LLC. GlobeNewswire +7.20%
Aug-16-21 07:21AM	electroCore (NASDAQ:ECOR) Is In A Good Position To Deliver On Growth Plans Simply Wall St. -5.33%
Aug-10-21 08:00AM	Study of Non-Invasive Vagus Nerve Stimulation (nVNS) Shows Improvement in PTSD Symptoms and Decreased Inflammatory Response to Stress GlobeNewswire
Aug-09-21 06:23AM	ECOR: Impressive Growth: Invigorating Guidance Zacks Small Cap Research
Aug-05-21 04:01PM	electroCore Announces Second Quarter 2021 Financial Results GlobeNewswire
Aug-02-21 08:00AM	electroCore to Present at the Canaccord Genuity Growth Conference GlobeNewswire
Jul-27-21 08:50AM	ElectroCore Stock Is Trading Higher As Ladenburg Initiates Coverage With $3 Price Target, Buy Rating Benzinga
08:00AM	electroCore Announces Issuance of New Patent for Migraine Treatment using Smartphones GlobeNewswire
Jul-22-21 08:00AM	electroCore to Announce Second Quarter 2021 Financial Results on Thursday, August 5th GlobeNewswire
Jul-19-21 08:00AM	electroCore announces Dr. Peter Staats to receive Lifetime Achievement Award from the American Society of Pain and Neuroscience GlobeNewswire
Jul-13-21 08:00AM	electroCore Provides Business Update and Select Second Quarter 2021 Financial Guidance GlobeNewswire
Jul-09-21 08:00AM	electroCore to Participate in the Ladenburg Thalmann 2021 Virtual Healthcare Conference GlobeNewswire +5.61%
Jun-30-21 11:46AM	ElectroCore Stock Dives On $18M Equity Raise Issued At Deep Discount Of 32% Benzinga -20.13%
08:30AM	electroCore Announces Pricing of $18.0 Million Public Offering of Common Stock GlobeNewswire
Jun-29-21 04:01PM	electroCore Announces Proposed Public Offering of Common Stock GlobeNewswire -5.70%
Jun-24-21 08:00AM	electroCore Announces Publication of Study on the Effect of non-invasive Vagus Nerve Stimulation (nVNS) on Cognitive Performance Caused by Sleep Deprivation GlobeNewswire
Jun-23-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with Kromax For Taiwan and China GlobeNewswire
Jun-22-21 09:48PM	Where Do Hedge Funds Stand On electroCore, Inc. (ECOR)? Insider Monkey
Jun-16-21 08:00AM	electroCore to Join Russell Microcap® Index GlobeNewswire
Jun-09-21 08:00AM	electroCore Completes Sale of $1.4 Million of NJ NOL Tax Benefits GlobeNewswire
Jun-02-21 07:30AM	electroCore Announces Publication of Study on Non-Invasive Vagus Nerve Stimulation (nVNS) to Improve Clinical Outcomes and Molecular Biomarkers in Parkinsons Disease Patients GlobeNewswire
May-27-21 07:15PM	35 of the Best Ideas Companies to Present at the Summer Solstice - Best Ideas from the Buy-Side Virtual Investor Conference on June 1-4, 2021 ACCESSWIRE +5.52%
May-26-21 07:30AM	electroCore to Present at Investor Conferences in June GlobeNewswire
May-17-21 09:05AM	ECOR: 1Q:21 Results Zacks Small Cap Research
May-06-21 04:12PM	electroCore Announces First Quarter 2021 Financial Results GlobeNewswire -7.27%
02:30PM	electroCore, Inc. to Host Earnings Call ACCESSWIRE
May-04-21 08:00AM	electroCore, Inc. Announces U.S. Department of Veterans Affairs Study of gammaCore Sapphire (Non-Invasive Vagus Nerve Stimulator) for the Treatment of Post-Traumatic Headache GlobeNewswire
Apr-29-21 08:00AM	electroCore to Announce First Quarter 2021 Financial Results on Thursday, May 6 GlobeNewswire
Apr-26-21 08:00AM	electroCore, Inc. Announces Johns Hopkins University School of Medicine Study of Non-Invasive Vagus Nerve Stimulation (nVNS) for Symptomatic Exacerbation of Nausea in Patients with Gastroparesis and Related Disorders GlobeNewswire +7.78%
Apr-20-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with East Agency For Qatar GlobeNewswire -5.95%
Apr-15-21 07:59AM	electroCore Announces Publication in Nature Reviews: Neurology Highlighting the Role of Non-Invasive Vagus Nerve Stimulation (nVNS) as an Emerging Treatment for Cluster Headache GlobeNewswire
Apr-13-21 07:59AM	electroCore Provides Business Update and Select First Quarter 2021 Financial Guidance GlobeNewswire
Apr-08-21 09:07AM	ElectroCore's Stock Is Trading Higher As nVNS Decreases Certain COVID-19-Associated Biomarkers Benzinga +5.10%
07:59AM	electroCore Announces Top Line Results from SAVIOR-1 study of Non-Invasive Vagus Nerve Stimulation (nVNS) in Hospitalized COVID-19 Patients GlobeNewswire
Apr-05-21 09:34AM	ElectroCore's Stock Is Trading Higher After Its Nerve Stimulator Wins Canadian Approval For Migraine Benzinga
07:59AM	electroCore, Inc. Announces Regulatory Approval in Canada GlobeNewswire
Mar-23-21 08:00AM	electroCore, Inc. Announces Exclusive Distribution Agreement with Silvert Medical Nv-Sa. For Western Europe GlobeNewswire
Mar-22-21 08:18AM	ECOR: More Distribution Agreements to Come Zacks Small Cap Research
Mar-15-21 08:56AM	Chief Medical Officer of electroCore, Inc. Peter Staats, M.D. Describes Potential At-Home Solutions to Reduce Common COVID-19 Symptoms Business Wire
Mar-11-21 04:05PM	electroCore Announces Fourth Quarter and Full Year 2020 Financial Results GlobeNewswire
02:30PM	electroCore, Inc. to Host Earnings Call ACCESSWIRE
Mar-04-21 08:30AM	electroCore to Announce Fourth Quarter and Year Ended December 31, 2020 Financial Results on Thursday, March 11 GlobeNewswire -12.89%
Mar-03-21 04:30PM	electroCore to Participate at Two Upcoming Investor Conferences GlobeNewswire -10.71%
Feb-28-21 04:00PM	electroCore Inc. Announces Exclusive Distribution Agreement with Medistar Following Regulatory Approval in Australia GlobeNewswire
Feb-24-21 07:45AM	Non-Invasive Vagus Nerve Stimulation (nVNS) Enters New Stage of COVID-19 Research Business Wire +13.27%
Feb-23-21 08:00AM	electroCore Announces Two-Year Extension of gammaCore Listing in the NHS Supply Chain Catalogue GlobeNewswire -14.92%
Feb-18-21 02:53AM	If You Had Bought electroCore (NASDAQ:ECOR) Shares A Year Ago You'd Have Earned 147% Returns Simply Wall St.
Feb-16-21 08:00AM	electroCore Announces 510(k) Clearance of gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) to Treat Adolescent Migraine GlobeNewswire
05:53AM	ECOR: Multiple Irons in the Fire Zacks Small Cap Research

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Errico Thomas J.	Director	May 19	Buy	0.40	15,197	6,024	1,426,700	May 23 08:30 AM
Errico Thomas J.	Director	May 18	Buy	0.40	42,032	16,746	1,411,503	May 19 09:00 PM
Errico Thomas J.	Director	May 17	Buy	0.39	42,771	16,741	1,369,471	May 19 09:00 PM
GANDOLFO JOHN P	Director	May 17	Buy	0.36	15,000	5,400	19,000	May 18 08:30 AM
Goldberger Daniel S	Chief Executive Officer	May 16	Buy	0.34	28,208	9,585	328,516	May 17 04:05 PM
POSNER BRIAN M	Chief Financial Officer	Dec 10	Buy	0.75	10,000	7,500	96,555	Dec 13 08:31 AM
Goldberger Daniel S	Chief Executive Officer	Dec 07	Buy	0.71	15,000	10,641	300,308	Dec 08 09:00 AM
Goldberger Daniel S	Chief Executive Officer	Nov 23	Buy	0.75	15,000	11,247	285,308	Nov 26 02:31 PM
POSNER BRIAN M	Chief Financial Officer	Nov 09	Buy	0.96	10,000	9,600	86,555	Nov 10 08:01 AM
Goldberger Daniel S	Chief Executive Officer	Oct 01	Option Exercise	0.00	53,764	0	270,308	Oct 05 08:00 AM
POSNER BRIAN M	Chief Financial Officer	Aug 17	Sale	0.92	6,478	5,960	76,555	Aug 19 05:19 PM
Errico Thomas J.	Director	Jul 02	Buy	1.00	50,000	50,000	1,326,700	Jul 07 05:00 PM
Goldberger Daniel S	Chief Executive Officer	Jul 02	Buy	1.00	50,000	50,000	216,544	Jul 07 05:01 PM
Moody Trevor J	Director	Jul 02	Buy	1.00	100,000	100,000	373,455	Jul 07 05:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience